xolremdi(mavorixafor)Medication DetailsX4 Pharmaceuticals, Inc.Usage: XOLREMDI is indicated for patients aged 12 and older with WHIM syndrome to increase circulating mature neutrophils and lymphocytes.Medication DetailsDrug Interactions